Every conversation you have with an AI — every decision, every debugging session, every architecture debate — disappears when the session ends. Six months of work, gone. You start over every time.

THE WEIGHT IS OVER — Danish drugmaker Novo Nordisk won FDA approval Thursday for a higher dose of its weight-loss drug Wegovy — a decision FDA Commissioner Marty Makary touted on social media because ...